Literature DB >> 22064994

p53-regulated increase in oxidative-stress--induced apoptosis in Fuchs endothelial corneal dystrophy: a native tissue model.

Behrooz Azizi1, Alireza Ziaei, Thomas Fuchsluger, Thore Schmedt, Yuming Chen, Ula V Jurkunas.   

Abstract

PURPOSE: This study compared susceptibility of Fuchs endothelial corneal dystrophy (FECD) and normal corneal endothelial cells (CECs) to oxidative stress, and studied the mechanism of oxidative-stress-induced apoptosis in FECD-affected endothelium.
METHODS: For in vitro studies, immortalized normal and FECD human corneal endothelial cell lines (HCECi and FECDi, respectively) were exposed to tert-butyl hydroperoxide (tBHP). Apoptotic cell populations were distinguished using flow cytometry. Reactive oxygen species production was measured by a horseradish peroxidase assay. For ex vivo studies, CECs were exposed to tBHP. Oxidative DNA damage and apoptosis were assessed by anti-8-hydroxydeoxyguanosine antibody and TUNEL assay, respectively. p53 and phospho-p53 levels were assessed by Western blot and immunohistochemistry.
RESULTS: Flow cytometry revealed a higher rate of apoptosis in FECDi than that in HCECi after exposure to 0.5 mM (P=0.010) and 1.0 mM tBHP (P=0.041). Further analysis showed increased production of H2O2 by FECDi than that by HCECi. Oxidative DNA damage increased in both normal and FECD CECs after exposure to 0.5 mM tBHP (P=0.031 and 0.022, respectively), leading to a 21% increase in TUNEL-positive CECs in FECD (P=0.015) but no change in normal. Baseline p53 expression was twofold higher in FECD than that in normal endothelium (P=0.002). Immunofluorescence revealed an increase in p53 and phospho-p53 levels in FECD compared with that in normal endothelium.
CONCLUSIONS: FECD CECs are more susceptible to oxidative DNA damage and oxidative-stress-induced apoptosis than normal. Increased activation of p53 in FECD suggests that it mediates cell death in susceptible CECs. The authors conclude that p53 plays a critical role in complex mechanisms regulating oxidative-stress-induced apoptosis in FECD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22064994      PMCID: PMC3250096          DOI: 10.1167/iovs.11-8312

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  16 in total

1.  Functional human corneal equivalents constructed from cell lines.

Authors:  M Griffith; R Osborne; R Munger; X Xiong; C J Doillon; N L Laycock; M Hakim; Y Song; M A Watsky
Journal:  Science       Date:  1999-12-10       Impact factor: 47.728

2.  p53 suppresses the Nrf2-dependent transcription of antioxidant response genes.

Authors:  Raffaella Faraonio; Paola Vergara; Domenico Di Marzo; Maria Giovanna Pierantoni; Maria Napolitano; Tommaso Russo; Filiberto Cimino
Journal:  J Biol Chem       Date:  2006-10-31       Impact factor: 5.157

3.  p53 mediates nontranscriptional cell death in dopaminergic cells in response to proteasome inhibition.

Authors:  Venugopalan D Nair; Kevin St P McNaught; Javier González-Maeso; Stuart C Sealfon; C Warren Olanow
Journal:  J Biol Chem       Date:  2006-10-23       Impact factor: 5.157

4.  Fuchs' corneal endothelial cells transduced with the human papilloma virus E6/E7 oncogenes.

Authors:  Y g He; J Weng; Q Li; H P Knauf; S E Wilson
Journal:  Exp Eye Res       Date:  1997-07       Impact factor: 3.467

5.  Efficacy of media enriched with nonlactate-generating substrate for organ preservation: in vitro and clinical studies using the cornea model.

Authors:  C H Chen; P Rama; A H Chen; A Franch; M Sulewski; S Orlin; E H Chen; S H Tseng; H Lee; C C Wang; G Y Hung; M Y Chan; M S Huang; S C Chen
Journal:  Transplantation       Date:  1999-03-27       Impact factor: 4.939

6.  ERKs and p38 kinase phosphorylate p53 protein at serine 15 in response to UV radiation.

Authors:  Q B She; N Chen; Z Dong
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

7.  Evidence of oxidative stress in the pathogenesis of fuchs endothelial corneal dystrophy.

Authors:  Ula V Jurkunas; Maya S Bitar; Toshinari Funaki; Behrooz Azizi
Journal:  Am J Pathol       Date:  2010-09-16       Impact factor: 4.307

8.  P53, CD95, cathepsin and survivin pathways in Fuchs' dystrophy and pseudophakic bullous keratopathy corneas.

Authors:  Nóra Szentmáry; Béla Szende; Ildikó Süveges
Journal:  Histol Histopathol       Date:  2008-08       Impact factor: 2.303

9.  Decreased expression of peroxiredoxins in Fuchs' endothelial dystrophy.

Authors:  Ula V Jurkunas; Ian Rawe; Maya S Bitar; Cheng Zhu; Deshea L Harris; Kathryn Colby; Nancy C Joyce
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03-31       Impact factor: 4.799

10.  ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes.

Authors:  Jiahao Liu; Weike Mao; Bo Ding; Chang-seng Liang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-09-05       Impact factor: 4.733

View more
  47 in total

1.  Association of smoking and other risk factors with Fuchs' endothelial corneal dystrophy severity and corneal thickness.

Authors:  Xiaolin Zhang; Robert P Igo; Jeremy Fondran; V Vinod Mootha; Matt Oliva; Kristin Hammersmith; Alan Sugar; Jonathan H Lass; Sudha K Iyengar
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-27       Impact factor: 4.799

2.  Activation of PINK1-Parkin-Mediated Mitophagy Degrades Mitochondrial Quality Control Proteins in Fuchs Endothelial Corneal Dystrophy.

Authors:  Takashi Miyai; Shivakumar Vasanth; Geetha Melangath; Neha Deshpande; Varun Kumar; Anne-Sophie Benischke; Yuming Chen; Marianne O Price; Francis W Price; Ula V Jurkunas
Journal:  Am J Pathol       Date:  2019-07-27       Impact factor: 4.307

3.  N-Acetylcysteine increases corneal endothelial cell survival in a mouse model of Fuchs endothelial corneal dystrophy.

Authors:  Eun Chul Kim; Huan Meng; Albert S Jun
Journal:  Exp Eye Res       Date:  2014-06-18       Impact factor: 3.467

4.  Unfolded protein response is activated in aged retinas.

Authors:  Austin R Lenox; Yogesh Bhootada; Oleg Gorbatyuk; Roderick Fullard; Marina Gorbatyuk
Journal:  Neurosci Lett       Date:  2015-10-17       Impact factor: 3.046

5.  NQO1 downregulation potentiates menadione-induced endothelial-mesenchymal transition during rosette formation in Fuchs endothelial corneal dystrophy.

Authors:  Kishore Reddy Katikireddy; Tomas L White; Taiga Miyajima; Shivakumar Vasanth; Duna Raoof; Yuming Chen; Marianne O Price; Francis W Price; Ula V Jurkunas
Journal:  Free Radic Biol Med       Date:  2017-12-30       Impact factor: 7.376

6.  Loss of NQO1 generates genotoxic estrogen-DNA adducts in Fuchs Endothelial Corneal Dystrophy.

Authors:  Taiga Miyajima; Geetha Melangath; Shan Zhu; Neha Deshpande; Shivakumar Vasanth; Bodhisattwa Mondal; Varun Kumar; Yuming Chen; Marianne O Price; Francis W Price; Eleanor G Rogan; Muhammad Zahid; Ula V Jurkunas
Journal:  Free Radic Biol Med       Date:  2019-12-17       Impact factor: 7.376

7.  The genetics of Fuchs' corneal dystrophy.

Authors:  Benjamin W Iliff; S Amer Riazuddin; John D Gottsch
Journal:  Expert Rev Ophthalmol       Date:  2012-08

8.  L450W and Q455K Col8a2 knock-in mouse models of Fuchs endothelial corneal dystrophy show distinct phenotypes and evidence for altered autophagy.

Authors:  Huan Meng; Mario Matthaei; Narendrakumar Ramanan; Rhonda Grebe; Shukti Chakravarti; Caroline L Speck; Martha Kimos; Neeraj Vij; Charles G Eberhart; Albert S Jun
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-28       Impact factor: 4.799

9.  Regional variability in corneal endothelial cell density between guttae and non-guttae areas in Fuchs endothelial corneal dystrophy.

Authors:  Stephan Ong Tone; Matthew James Bruha; Myriam Böhm; Christina Prescott; Ula Jurkunas
Journal:  Can J Ophthalmol       Date:  2019-06-17       Impact factor: 1.882

10.  Decreased DJ-1 leads to impaired Nrf2-regulated antioxidant defense and increased UV-A-induced apoptosis in corneal endothelial cells.

Authors:  Cailing Liu; Yuming Chen; Irene E Kochevar; Ula V Jurkunas
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-07-31       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.